Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/10/1998 | EP0846700A1 Pollen Allergens |
06/10/1998 | EP0846680A1 Cationic lipids for gene therapy |
06/10/1998 | EP0846186A2 Extraction, amplification and sequential hybridisation of fungus cell dna and a process for detecting fungus cells in clinical material |
06/10/1998 | EP0846185A1 T-pa polymorphism and use thereof in diagnosis of risk of thrombus associated disease |
06/10/1998 | EP0846183A2 High efficiency retroviral packaging system |
06/10/1998 | EP0846182A1 Expression systems |
06/10/1998 | EP0846181A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
06/10/1998 | EP0846180A1 Transgenic plantcells and plants having an increased glycolysis rate |
06/10/1998 | EP0846179A2 Dna constructs |
06/10/1998 | EP0846177A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
06/10/1998 | EP0846175A1 Process for preparing daunorubicin |
06/10/1998 | EP0846174A1 Methods for enhancing the production of interferon in cell culture |
06/10/1998 | EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
06/10/1998 | EP0846172A2 Assay for identifying genes causing chromosome non-disjunction |
06/10/1998 | EP0846171A2 Chromosome 1 gene and gene products related to alzheimer's disease |
06/10/1998 | EP0846170A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
06/10/1998 | EP0846169A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES |
06/10/1998 | EP0846167A1 Nuclear-encoded transcription system in plastids of higher plants |
06/10/1998 | EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
06/10/1998 | EP0846164A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
06/10/1998 | EP0846161A1 Release of intracellular material |
06/10/1998 | EP0846160A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
06/10/1998 | EP0846128A2 Antimicrobial cationic peptides and methods of screening for the same |
06/10/1998 | EP0846124A1 Chemical, biochemical and biological processing in thin films |
06/10/1998 | EP0846002A1 Circular rna and uses thereof |
06/10/1998 | EP0846001A1 Control of cd44 gene expression for therapeutic use |
06/10/1998 | EP0845981A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
06/10/1998 | EP0845972A1 Use of mutated subtilisin protease in cosmetic products |
06/10/1998 | EP0845939A2 Lysosomal proteins produced in the milk of transgenic animals |
06/10/1998 | EP0836652A4 Methods, kits, and compositions for diagnosing papillomavirus infection |
06/10/1998 | EP0797685A4 ANALYSIS OF GENE EXPRESSION BY DISPLAY OF 3'-END RESTRICTION FRAGMENTS OF cDNAs |
06/10/1998 | EP0767797A4 Plant peptide transport gene |
06/10/1998 | EP0733106A4 Plant arabinogalactan protein (agp) genes |
06/10/1998 | EP0721346B1 Methods for inducing antigen-specific t cell tolerance |
06/10/1998 | EP0714403B1 Aqueous multiple-phase isolation of polypeptide |
06/10/1998 | EP0693131A4 Cell free system for protein synthesis and use of chaperone proteins therein |
06/10/1998 | EP0662154B1 Conjugate for the detection and/or assay of a biological compound |
06/10/1998 | EP0502108B1 Device for processing biological specimens for analysis of nucleic acids |
06/10/1998 | EP0500699B1 Cross-protective salmonella vaccines |
06/10/1998 | EP0309569B1 Production of purified, biologically active, bacterially produced recombinant human csf-1 |
06/10/1998 | DE19650714A1 Genfallen-Konstrukt zur Identifizierung und Isolierung von Genen Gene-trapping construct for the identification and isolation of genes |
06/10/1998 | DE19650216A1 Verfahren zur Beeinflussung der Chlorophyllbiosynthese in Pflanzen Method for influencing the chlorophyll biosynthesis in plants |
06/10/1998 | DE19650142A1 nCL-3, a truncated calpain |
06/10/1998 | CN1184531A Method for diagnosing a patient for chlamydia |
06/10/1998 | CN1184507A Endo beta-1, 4 -glucanase from aspergillus |
06/10/1998 | CN1184506A DNA molecule relating to suppression of gene expression and novel protein |
06/10/1998 | CN1184505A Vaccines for plague |
06/10/1998 | CN1184504A Recombinant baculovirus insecticides |
06/10/1998 | CN1184479A Substrates for beta-lactamase and uses thereof |
06/10/1998 | CN1184431A Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
06/10/1998 | CN1184159A Improved fermentative carotenoid production |
06/10/1998 | CN1184157A Method for producing nucleoside-5' -phosphate ester |
06/10/1998 | CN1184156A Phytase and the clone and expression of its gene |
06/10/1998 | CN1184114A Alpha derivative of human tumor necrosin and its preparation |
06/10/1998 | CN1038692C Method for isolating and purifing DNA molecules and apparatus thereofor |
06/09/1998 | USRE35823 Proteins useful in the regulation of κB-containing genes |
06/09/1998 | US5763748 Genetic engineered dna transforming plant cell to excrete human serum albumin |
06/09/1998 | US5763740 Method of detecting prions in a sample and transgenic animal used for same |
06/09/1998 | US5763739 Genetic engineering |
06/09/1998 | US5763595 Nucleic acid ligands which bind covalently with protein |
06/09/1998 | US5763593 Nucleic acids encoding TBP-associated global negative regulator |
06/09/1998 | US5763589 Human membrane protein |
06/09/1998 | US5763588 Pyrimidine derivatives for labeled binding partners |
06/09/1998 | US5763578 All-trans retinaldehyde binding protein, and antibodies thereto |
06/09/1998 | US5763575 Agonist and antagonist peptides of the C140 receptor |
06/09/1998 | US5763572 HTLV-II peptide antigens |
06/09/1998 | US5763571 Amino acid sequences which inhibit binding |
06/09/1998 | US5763569 Polypeptides as calcium receptors to generate antibodies |
06/09/1998 | US5763566 Systematic evolution of ligands by exponential enrichment: tissue SELEX |
06/09/1998 | US5763416 Stimulating bone repair and regeneration |
06/09/1998 | US5763385 Genetic engineered culture product; stability, heat resistane, oxidation resistance |
06/09/1998 | US5763284 Methods for peptide synthesis and purification |
06/09/1998 | US5763276 Processes for the purification of human recombinant decorin and the detection of guandinium ions |
06/09/1998 | US5763274 Antibody 103B2 |
06/09/1998 | US5763270 Plasmid for delivery of nucleic acids to cells and methods of use |
06/09/1998 | US5763269 Recombinant infectious bovine rhinotrocheitis virus |
06/09/1998 | US5763268 Hepatitis delta virus compositions and expression vectors |
06/09/1998 | US5763260 Method to alter the properties of acetylated xylan |
06/09/1998 | US5763257 Modified subtilisins having amino acid alterations |
06/09/1998 | US5763256 Subtilisin-type serine protease having catalytic serine at or near amino terminus replaced by or converted to cysteine, specified proline replaced with different helix-forming amino acid |
06/09/1998 | US5763254 Enzyme capable of degrading cellulose or hemicellulose |
06/09/1998 | US5763253 Methods of preparing tissue plasiminogen activator derivative composition |
06/09/1998 | US5763251 Viral products |
06/09/1998 | US5763250 Chimeric toxins |
06/09/1998 | US5763247 Nucleotide fragments and uses thereof for obtaining bactericide-producing compositions |
06/09/1998 | US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus |
06/09/1998 | US5763245 Providing a 3-hydroxysteroid oxidase and cry1a bacillus thuringiensis protein in an insecticidally effective amount for ingestion by insect lepidopteran; genetic engineering |
06/09/1998 | US5763244 Method for cloning and expression of phosphorylation-dependent protein kinase |
06/09/1998 | US5763243 Using a genetic engineered dna to repress the dominant negative gene |
06/09/1998 | US5763242 Method for increasing transduction efficiency of recombinant retroviral vectors |
06/09/1998 | US5763241 Insect resistant plants |
06/09/1998 | US5763240 In vivo homologous sequence targeting in eukaryotic cells |
06/09/1998 | US5763239 Isolating genomic dna population from environmental sample, analyzing complexity, amplifying copy number or recovering fraction having desired characteristic, normalizing representation |
06/09/1998 | US5763236 Method for producing ketone or aldehyde using an alcohol dehydrogenase of Candida Parapsilosis |
06/09/1998 | US5763227 Process for the production of primers and template bank therefor |
06/09/1998 | US5763225 Synthesis of peptides as cloned ubiquitin extensions |
06/09/1998 | US5763224 Genetic engineered complementary dna |
06/09/1998 | US5763223 DNA encoding a cytokine that induces apoptosis |
06/09/1998 | US5763221 Obtained by transforming hyphomycetes by plasmid constructed with promoter, terminator, marker gene and target aspergillus niger alpha-amylase gene |
06/09/1998 | US5763220 Human apoptosis-related calcium-binding protein |